OM
FLXN

Opaleye Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Opaleye Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-281,600
Closed -$2.22M – 57
2020
Q1 		$2.22M Sell
281,600
-133,900
-32% -$2.02M 0.59% 35
2019
Q4 		$8.6M Buy
415,500
+310,500
+296% +$5.24M 1.69% 27
2019
Q3 		$1.44M Buy
+105,000
New +$1.25M 0.52% 40
2014
Q2 		– Sell
-135,500
Closed -$2.23M – 35
2014
Q1 		$2.23M Buy
+135,500
New +$2.34M 1.65% 19

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return